PsyLabs is a producer of psychedelic active pharmaceutical ingredients, operating from an ISO 22000-certified facility in Southern Africa. The company holds federal licenses to cultivate, extract, and export psychedelic compounds, including psilocybin and ibogaine, to legal medical and research markets.
Leadership & Board
Current Number of Employees15
Current LinkedIn Followers1,379
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
PsyLabs had 15 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
15Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
PsyLabs had 1,379 followers as of September 7, 2026. The number of followers increased by 5 (0.36%) week-over-week.
1,379Latest Followers Count
5(0.36%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.